GERON CORP (GERN) Pre-Tax Margin
Complete source-backed pre-tax margin history.
- Available history
- 2022-12-31 to 2023-12-31
- Data captured
Historical Pre-Tax Margin
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|
| 2023-12-31 | -76681.01% |
|---|
| 2022-12-31 | -23809.06% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
|---|
| Wave Life Sciences, Inc. (WVE) | | $0.780B | -5.56 |
|---|
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
|---|
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
|---|